25 XP   0   0   10

Zhejiang Jingxin Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Jingxin Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Jingxin Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Jingxin Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Jingxin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Jingxin Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Jingxin Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.43
Expected worth in 1 year
¥8.14
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥2.91
Return On Investment
23.9%

For what price can you sell your share?

Current Price per Share
¥12.17
Expected price per share
¥8.28 - ¥14.22
How sure are you?
50%

1. Valuation of Zhejiang Jingxin Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥12.17

Intrinsic Value Per Share

¥1.49 - ¥3.54

Total Value Per Share

¥7.93 - ¥9.97

2. Growth of Zhejiang Jingxin Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Jingxin Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$765m$714.2m$50.8m6.6%

How much money is Zhejiang Jingxin Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$85.4m$91.4m-$5.9m-7.0%
Net Profit Margin15.5%17.5%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Jingxin Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Jingxin Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Jingxin Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Jingxin Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Jingxin Pharmaceutical Co Ltd is ¥12.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Jingxin Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Jingxin Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.43. Based on the TTM, the Book Value Change Per Share is ¥0.43 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.66 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.30 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.100.8%0.100.8%0.100.9%0.100.8%0.070.5%
Usd Book Value Change Per Share0.060.5%0.060.5%0.090.8%0.060.5%0.080.6%
Usd Dividend Per Share0.040.3%0.040.3%0.040.3%0.040.3%0.020.2%
Usd Total Gains Per Share0.100.8%0.100.8%0.131.1%0.100.8%0.100.8%
Usd Price Per Share1.76-1.76-1.68-1.52-1.89-
Price to Earnings Ratio17.70-17.70-16.22-15.80-49.39-
Price-to-Total Gains Ratio17.48-17.48-12.64-16.75-15.09-
Price to Book Ratio1.98-1.98-2.03-2.10-4.21-
Price-to-Total Gains Ratio17.48-17.48-12.64-16.75-15.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.680677
Number of shares594
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.04
Usd Book Value Change Per Share0.060.06
Usd Total Gains Per Share0.100.10
Gains per Quarter (594 shares)59.6960.61
Gains per Year (594 shares)238.75242.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
19814022990153232
2197281468180305474
3295421707269458716
4394561946359611958
549270211854497631200
659184214245399161442
7689982166362810691684
87881122190271812211926
98861263214180813742168
109841403238089815272410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.01.095.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%22.01.00.095.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.02.091.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%22.01.00.095.7%

Fundamentals of Zhejiang Jingxin Pharmaceutical Co Ltd

About Zhejiang Jingxin Pharmaceutical Co Ltd

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, Cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, sitagliptin, clopidogrel bisulfate, ticagrelor, rivaroxaban, apixaban, sisapele, esomeprazole, levetiracetam, bovaracetam, sertraline hydrochloride, pramipexole hydrochloride, rivastigmine bitartrate, memantine hydrochloride, and paliperidone. It also provides intermediates; and medical display products, such as diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, and ultrasonic medical displays. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1990 and is headquartered in Xinchang, China.

Fundamental data was last updated by Penke on 2024-05-05 21:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Jingxin Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 15.5% means that ¥0.15 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 15.5%. The company is making a huge profit. +2
  • The TTM is 15.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.5%TTM15.5%0.0%
TTM15.5%YOY17.5%-2.0%
TTM15.5%5Y17.1%-1.7%
5Y17.1%10Y14.2%+2.9%
1.1.2. Return on Assets

Shows how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.7% Return on Assets means that Zhejiang Jingxin Pharmaceutical Co Ltd generated ¥0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 7.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY9.0%-1.2%
TTM7.7%5Y9.4%-1.7%
5Y9.4%10Y7.7%+1.7%
1.1.3. Return on Equity

Shows how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.2% Return on Equity means Zhejiang Jingxin Pharmaceutical Co Ltd generated ¥0.11 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 11.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.2%TTM11.2%0.0%
TTM11.2%YOY12.9%-1.6%
TTM11.2%5Y13.5%-2.3%
5Y13.5%10Y10.9%+2.6%

1.2. Operating Efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Jingxin Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY19.6%-19.6%
TTM-5Y13.1%-13.1%
5Y13.1%10Y11.9%+1.2%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are ¥1.34 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 1.335. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.335. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.335TTM1.3350.000
TTM1.335YOY1.293+0.042
TTM1.3355Y1.261+0.075
5Y1.26110Y1.203+0.058

1.3. Liquidity of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Jingxin Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.62 means the company has ¥1.62 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 1.616. The company is able to pay all its short-term debts. +1
  • The TTM is 1.616. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.616TTM1.6160.000
TTM1.616YOY1.807-0.191
TTM1.6165Y1.949-0.332
5Y1.94910Y1.972-0.023
1.3.2. Quick Ratio

Measures if Zhejiang Jingxin Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.35 means the company can pay off ¥0.35 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.348. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.348. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.348TTM0.3480.000
TTM0.348YOY0.463-0.115
TTM0.3485Y0.782-0.434
5Y0.78210Y1.151-0.369

1.4. Solvency of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Jingxin Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.31 means that Zhejiang Jingxin Pharmaceutical Co Ltd assets are financed with 30.6% credit (debt) and the remaining percentage (100% - 30.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.306. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.306. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.306TTM0.3060.000
TTM0.306YOY0.298+0.009
TTM0.3065Y0.299+0.007
5Y0.29910Y0.279+0.020
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Jingxin Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 44.4% means that company has ¥0.44 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.444. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.444. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.444TTM0.4440.000
TTM0.444YOY0.426+0.018
TTM0.4445Y0.431+0.012
5Y0.43110Y0.394+0.037

2. Market Valuation of Zhejiang Jingxin Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Jingxin Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 17.70 means the investor is paying ¥17.70 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The EOD is 16.931. Based on the earnings, the company is fair priced.
  • The MRQ is 17.696. Based on the earnings, the company is fair priced.
  • The TTM is 17.696. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.931MRQ17.696-0.765
MRQ17.696TTM17.6960.000
TTM17.696YOY16.225+1.472
TTM17.6965Y15.800+1.896
5Y15.80010Y49.390-33.590
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The EOD is 38.338. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 40.071. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 40.071. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD38.338MRQ40.071-1.733
MRQ40.071TTM40.0710.000
TTM40.071YOY30.827+9.244
TTM40.0715Y-10.523+50.594
5Y-10.52310Y114.728-125.252
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Jingxin Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The EOD is 1.891. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.977. Based on the equity, the company is underpriced. +1
  • The TTM is 1.977. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.891MRQ1.977-0.085
MRQ1.977TTM1.9770.000
TTM1.977YOY2.028-0.051
TTM1.9775Y2.096-0.119
5Y2.09610Y4.215-2.119
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Jingxin Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4280.4280%0.663-36%0.465-8%0.548-22%
Book Value Per Share--6.4346.4340%6.007+7%5.324+21%4.228+52%
Current Ratio--1.6161.6160%1.807-11%1.949-17%1.972-18%
Debt To Asset Ratio--0.3060.3060%0.298+3%0.299+2%0.279+10%
Debt To Equity Ratio--0.4440.4440%0.426+4%0.431+3%0.394+13%
Dividend Per Share--0.3000.3000%0.3000%0.274+10%0.176+71%
Eps--0.7190.7190%0.751-4%0.701+3%0.478+50%
Free Cash Flow Per Share--0.3170.3170%0.395-20%0.221+44%0.209+52%
Free Cash Flow To Equity Per Share--0.3170.3170%0.177+80%0.036+772%0.278+14%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.536--------
Intrinsic Value_10Y_min--1.495--------
Intrinsic Value_1Y_max--0.252--------
Intrinsic Value_1Y_min--0.196--------
Intrinsic Value_3Y_max--0.835--------
Intrinsic Value_3Y_min--0.552--------
Intrinsic Value_5Y_max--1.512--------
Intrinsic Value_5Y_min--0.866--------
Market Cap10478722832.640-5%10952290660.80010952290660.8000%10487334925.200+4%9589997440.572+14%11850797480.224-8%
Net Profit Margin--0.1550.1550%0.175-12%0.171-10%0.142+9%
Operating Margin----0%0.196-100%0.131-100%0.119-100%
Operating Ratio--1.3351.3350%1.293+3%1.261+6%1.203+11%
Pb Ratio1.891-5%1.9771.9770%2.028-3%2.096-6%4.215-53%
Pe Ratio16.931-5%17.69617.6960%16.225+9%15.800+12%49.390-64%
Price Per Share12.170-5%12.72012.7200%12.180+4%11.018+15%13.665-7%
Price To Free Cash Flow Ratio38.338-5%40.07140.0710%30.827+30%-10.523+126%114.728-65%
Price To Total Gains Ratio16.726-5%17.48217.4820%12.642+38%16.753+4%15.094+16%
Quick Ratio--0.3480.3480%0.463-25%0.782-55%1.151-70%
Return On Assets--0.0770.0770%0.090-14%0.094-18%0.077+0%
Return On Equity--0.1120.1120%0.129-13%0.135-17%0.109+3%
Total Gains Per Share--0.7280.7280%0.963-24%0.739-2%0.724+0%
Usd Book Value--765095447.623765095447.6230%714249085.023+7%640595096.836+19%508450446.071+50%
Usd Book Value Change Per Share--0.0590.0590%0.092-36%0.064-8%0.076-22%
Usd Book Value Per Share--0.8890.8890%0.830+7%0.735+21%0.584+52%
Usd Dividend Per Share--0.0410.0410%0.0410%0.038+10%0.024+71%
Usd Eps--0.0990.0990%0.104-4%0.097+3%0.066+50%
Usd Free Cash Flow--37745965.31737745965.3170%46982244.469-20%26274770.046+44%24980673.476+51%
Usd Free Cash Flow Per Share--0.0440.0440%0.055-20%0.031+44%0.029+52%
Usd Free Cash Flow To Equity Per Share--0.0440.0440%0.024+80%0.005+772%0.038+14%
Usd Market Cap1447111623.188-5%1512511340.2561512511340.2560%1448300953.170+4%1324378646.543+14%1636595132.019-8%
Usd Price Per Share1.681-5%1.7571.7570%1.682+4%1.522+15%1.887-7%
Usd Profit--85469818.45985469818.4590%91457253.089-7%84755267.057+1%57837711.434+48%
Usd Revenue--552239143.864552239143.8640%521996772.025+6%497696153.404+11%382346491.293+44%
Usd Total Gains Per Share--0.1000.1000%0.133-24%0.102-2%0.100+0%
 EOD+4 -4MRQTTM+0 -0YOY+11 -245Y+19 -1610Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Jingxin Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.931
Price to Book Ratio (EOD)Between0-11.891
Net Profit Margin (MRQ)Greater than00.155
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.348
Current Ratio (MRQ)Greater than11.616
Debt to Asset Ratio (MRQ)Less than10.306
Debt to Equity Ratio (MRQ)Less than10.444
Return on Equity (MRQ)Greater than0.150.112
Return on Assets (MRQ)Greater than0.050.077
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Jingxin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.814
Ma 20Greater thanMa 5010.726
Ma 50Greater thanMa 10010.765
Ma 100Greater thanMa 20011.256
OpenGreater thanClose12.030
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,986,557
Total Liabilities2,446,402
Total Stockholder Equity5,512,374
 As reported
Total Liabilities 2,446,402
Total Stockholder Equity+ 5,512,374
Total Assets = 7,986,557

Assets

Total Assets7,986,557
Total Current Assets3,353,735
Long-term Assets4,632,822
Total Current Assets
Cash And Cash Equivalents 1,460,813
Short-term Investments 150,956
Net Receivables 571,456
Inventory 652,687
Other Current Assets 435,227
Total Current Assets  (as reported)3,353,735
Total Current Assets  (calculated)3,271,139
+/- 82,596
Long-term Assets
Property Plant Equipment 2,300,196
Goodwill 348,485
Intangible Assets 401,264
Long-term Assets Other 521,235
Long-term Assets  (as reported)4,632,822
Long-term Assets  (calculated)3,571,180
+/- 1,061,643

Liabilities & Shareholders' Equity

Total Current Liabilities2,074,759
Long-term Liabilities371,643
Total Stockholder Equity5,512,374
Total Current Liabilities
Short Long Term Debt 279,091
Accounts payable 941,160
Other Current Liabilities 4,263
Total Current Liabilities  (as reported)2,074,759
Total Current Liabilities  (calculated)1,224,514
+/- 850,245
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt31,228
Long-term Liabilities Other 3,203
Long-term Liabilities  (as reported)371,643
Long-term Liabilities  (calculated)34,430
+/- 337,213
Total Stockholder Equity
Retained Earnings 2,540,094
Total Stockholder Equity (as reported)5,512,374
Total Stockholder Equity (calculated)2,540,094
+/- 2,972,281
Other
Capital Stock861,029
Common Stock Shares Outstanding 861,029
Net Invested Capital 5,791,466
Net Working Capital 1,278,976
Property Plant and Equipment Gross 3,333,533



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
152,501
182,372
258,805
465,135
568,915
772,847
1,015,786
953,084
917,221
949,146
1,192,559
1,300,978
1,324,631
2,064,659
2,939,892
3,290,626
4,903,994
4,991,769
5,625,088
5,666,247
6,415,365
7,362,556
7,986,557
7,986,5577,362,5566,415,3655,666,2475,625,0884,991,7694,903,9943,290,6262,939,8922,064,6591,324,6311,300,9781,192,559949,146917,221953,0841,015,786772,847568,915465,135258,805182,372152,501
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,433,273
1,562,878
2,996,031
3,036,803
3,485,166
3,125,014
3,229,523
3,281,166
3,353,735
3,353,7353,281,1663,229,5233,125,0143,485,1663,036,8032,996,0311,562,8781,433,27300000000000000
       Cash And Cash Equivalents 
4,289
15,051
21,976
77,658
67,973
106,588
228,735
227,614
222,822
102,315
321,899
312,921
197,458
380,118
432,610
261,713
333,547
410,872
493,219
915,349
1,554,792
1,548,475
1,460,813
1,460,8131,548,4751,554,792915,349493,219410,872333,547261,713432,610380,118197,458312,921321,899102,315222,822227,614228,735106,58867,97377,65821,97615,0514,289
       Short-term Investments 
5,000
0
0
0
0
0
0
0
0
0
74
51
0
348,000
376,650
620,000
1,645,000
1,445,000
1,948,403
1,178,834
422,396
366,885
150,956
150,956366,885422,3961,178,8341,948,4031,445,0001,645,000620,000376,650348,000051740000000005,000
       Net Receivables 
35,579
32,038
44,416
58,243
40,882
58,437
102,436
102,201
99,542
100,247
91,585
132,529
181,907
226,970
358,722
404,836
691,532
558,004
517,136
334,736
584,645
474,434
571,456
571,456474,434584,645334,736517,136558,004691,532404,836358,722226,970181,907132,52991,585100,24799,542102,201102,43658,43740,88258,24344,41632,03835,579
       Other Current Assets 
14,315
23,189
40,473
58,433
67,123
23,997
51,238
17,533
20,594
132,054
23,531
14,425
11,507
5,468
13,411
22,204
29,866
14,409
19,378
24,347
17,734
22,078
435,227
435,22722,07817,73424,34719,37814,40929,86622,20413,4115,46811,50714,42523,531132,05420,59417,53351,23823,99767,12358,43340,47323,18914,315
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,727,748
1,907,963
1,956,236
2,139,922
2,541,233
3,185,842
4,081,390
4,632,822
4,632,8224,081,3903,185,8422,541,2332,139,9221,956,2361,907,9631,727,748000000000000000
       Property Plant Equipment 
28,327
48,529
91,341
136,994
322,587
449,245
490,846
501,173
436,605
428,366
552,148
496,974
592,576
614,130
664,431
705,400
731,936
831,832
962,422
1,078,812
1,262,897
1,632,141
2,300,196
2,300,1961,632,1411,262,8971,078,812962,422831,832731,936705,400664,431614,130592,576496,974552,148428,366436,605501,173490,846449,245322,587136,99491,34148,52928,327
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
423,403
414,403
257,886
257,886
257,886
257,886
257,886
348,485
348,485
348,485348,485257,886257,886257,886257,886257,886414,403423,40300000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,118
279,717
598,306
530,327
0
0
0
0
0
00000530,327598,306279,71758,11800000000000000
       Intangible Assets 
7,912
19,344
21,755
68,942
72,007
75,670
0
25
0
0
0
35,809
31,918
108,372
190,581
174,389
157,924
141,235
166,572
150,768
137,732
418,588
401,264
401,264418,588137,732150,768166,572141,235157,924174,389190,581108,37231,91835,80900025075,67072,00768,94221,75519,3447,912
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,449
9,848
8,247
77,210
246,804
732,016
861,189
521,235
521,235861,189732,016246,80477,2108,2479,8489,449000000000000000
> Total Liabilities 
111,828
119,352
170,364
181,109
279,270
478,232
716,176
649,891
610,056
629,020
426,392
528,398
506,652
666,121
679,390
864,229
938,431
1,418,374
1,914,376
1,733,578
1,577,711
2,190,586
2,446,402
2,446,4022,190,5861,577,7111,733,5781,914,3761,418,374938,431864,229679,390666,121506,652528,398426,392629,020610,056649,891716,176478,232279,270181,109170,364119,352111,828
   > Total Current Liabilities 
110,796
98,284
139,276
142,019
278,238
428,793
537,067
628,995
540,133
457,232
356,277
461,406
454,850
604,004
616,983
798,358
869,400
1,353,147
1,770,292
1,546,859
1,385,116
1,815,386
2,074,759
2,074,7591,815,3861,385,1161,546,8591,770,2921,353,147869,400798,358616,983604,004454,850461,406356,277457,232540,133628,995537,067428,793278,238142,019139,27698,284110,796
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200,000
0
150,000
358,500
0
0
0
0
0000358,500150,0000200,000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200,000
0
150,000
358,500
300,125
148,329
238,584
279,091
279,091238,584148,329300,125358,500150,0000200,000000000000000000
       Accounts payable 
38,066
32,551
58,998
92,190
110,076
187,229
260,933
208,506
244,043
179,609
111,803
211,075
245,423
403,071
316,154
316,999
368,304
426,514
456,561
369,053
435,052
719,124
941,160
941,160719,124435,052369,053456,561426,514368,304316,999316,154403,071245,423211,075111,803179,609244,043208,506260,933187,229110,07692,19058,99832,55138,066
       Other Current Liabilities 
37,980
23,983
20,278
22,829
36,103
30,064
46,134
42,489
48,790
43,031
28,882
47,065
84,980
161,778
211,057
239,854
423,626
644,570
813,045
696,238
603,986
9,275
4,263
4,2639,275603,986696,238813,045644,570423,626239,854211,057161,77884,98047,06528,88243,03148,79042,48946,13430,06436,10322,82920,27823,98337,980
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65,870
69,031
77,369
144,084
186,719
192,595
375,199
371,643
371,643375,199192,595186,719144,08477,36969,03165,870000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-200,000
0
-150,000
-358,500
17,887
6,513
42,979
31,228
31,22842,9796,51317,887-358,500-150,0000-200,000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
694
741
745
742
817
743
1,941
3,203
3,2031,941743817742745741694000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,849
10,919
19,925
13,096
34,283
74,027
54,245
26,711
0
026,71154,24574,02734,28313,09619,92510,91922,84900000000000000
> Total Stockholder Equity
40,673
63,020
88,441
279,526
282,644
293,136
298,179
299,290
303,042
315,938
766,167
772,580
817,978
1,398,538
2,216,882
2,381,008
3,920,618
3,561,772
3,696,080
3,917,603
4,817,411
5,146,123
5,512,374
5,512,3745,146,1234,817,4113,917,6033,696,0803,561,7723,920,6182,381,0082,216,8821,398,538817,978772,580766,167315,938303,042299,290298,179293,136282,644279,52688,44163,02040,673
   Common Stock
30,000
50,100
50,100
67,700
67,700
101,550
101,550
101,550
101,550
101,550
126,331
126,331
252,663
286,451
319,588
639,176
736,124
724,872
724,872
705,508
905,319
861,029
0
0861,029905,319705,508724,872724,872736,124639,176319,588286,451252,663126,331126,331101,550101,550101,550101,550101,55067,70067,70050,10050,10030,000
   Retained Earnings 
2,382
9,022
30,615
52,576
55,142
64,918
69,693
50,470
53,554
66,100
93,302
98,024
140,321
246,214
369,290
520,273
720,774
946,813
1,345,279
1,766,406
2,148,981
2,553,615
2,540,094
2,540,0942,553,6152,148,9811,766,4061,345,279946,813720,774520,273369,290246,214140,32198,02493,30266,10053,55450,47069,69364,91855,14252,57630,6159,0222,382
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114
260,839
76,001
4,989
6,370
8,046
11,310
0
011,3108,0466,3704,98976,001260,839114000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,998,835
Cost of Revenue-1,976,488
Gross Profit2,022,3472,022,347
 
Operating Income (+$)
Gross Profit2,022,347
Operating Expense-3,362,392
Operating Income636,443-1,340,045
 
Operating Expense (+$)
Research Development400,935
Selling General Administrative849,445
Selling And Marketing Expenses0
Operating Expense3,362,3921,250,380
 
Net Interest Income (+$)
Interest Income60,269
Interest Expense-7,315
Other Finance Cost-2,561
Net Interest Income50,394
 
Pretax Income (+$)
Operating Income636,443
Net Interest Income50,394
Other Non-Operating Income Expenses0
Income Before Tax (EBT)708,041636,443
EBIT - interestExpense = -7,315
618,898
626,213
Interest Expense7,315
Earnings Before Interest and Taxes (EBIT)0715,356
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax708,041
Tax Provision-84,623
Net Income From Continuing Ops623,418623,418
Net Income618,898
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-50,394
 

Technical Analysis of Zhejiang Jingxin Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Jingxin Pharmaceutical Co Ltd. The general trend of Zhejiang Jingxin Pharmaceutical Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Jingxin Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Jingxin Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 12.15 < 12.93 < 14.22.

The bearish price targets are: 11.46 > 9.96 > 8.28.

Tweet this
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Jingxin Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current macd is 0.28313374.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jingxin Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Jingxin Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Jingxin Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current adx is 25.83.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Jingxin Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Jingxin Pharmaceutical Co Ltd. The current sar is 10.69.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current rsi is 72.81. The current phase is Overbought in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bear market: Short-term excessive buying, potential for relief decline. Consider shorting, be cautious of potential pullback. -1
  • Trending up: The RSI is trending up. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Jingxin Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jingxin Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current cci is 177.58.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current cmo is 63.09.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Jingxin Pharmaceutical Co Ltd. The current willr is -0.89686099.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Jingxin Pharmaceutical Co Ltd.

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current atr is 0.35693304.

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current obv is 446,755,050.

Zhejiang Jingxin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current mfi is 78.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Jingxin Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Jingxin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.814
Ma 20Greater thanMa 5010.726
Ma 50Greater thanMa 10010.765
Ma 100Greater thanMa 20011.256
OpenGreater thanClose12.030
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Jingxin Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Jingxin Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Jingxin Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Jingxin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Jingxin Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Jingxin Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Jingxin Pharmaceutical Co Ltd in your mailbox!